World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 26 September 2016
Main ID:  NCT02263183
Date of registration: 22/09/2014
Prospective Registration: No
Primary sponsor: Malaysia Palm Oil Board
Public title: Red Palm Olein and Cardiovascular Health
Scientific title: Red Palm Olein and Cardiovascular Health
Date of first enrolment: January 2013
Target sample size: 53
Recruitment status: Active, not recruiting
URL:  https://clinicaltrials.gov/show/NCT02263183
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Investigator), Primary Purpose: Prevention  
Phase:  N/A
Countries of recruitment
Malaysia
Contacts
Name:     Radhika Loganathan, Masters
Address: 
Telephone:
Email:
Affiliation:  Malaysia Palm Oil Board
Key inclusion & exclusion criteria

Inclusion Criteria:

- Abdominally obese males and females (waist circumference > 90 cm for male, > 80 cm
for female), age between 20-60 years and BMI =18.5kgm2 will be recruited.

Exclusion Criteria:

- Medical history of myocardial infarction, angina, thrombosis, stroke, cancer or
diabetes

- Blood glucose; >7.0 mmol/L

- Serum triacylglycerol; >4.5 mmol/L

- Serum total cholesterol; >6.5 mmol/L

- Body mass index <18.5 kg/m2

- Current use of antihypertensive or lipid lowering medication

- Alcohol intake exceeding a moderate intake (>28 units per week)

- Breastfeeding or pregnant

- Consume supplement such as herbs and hormone pills

- Smoking



Age minimum: 18 Years
Age maximum: 60 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Cardiovascular Risk Factor
Intervention(s)
Dietary Supplement: Palm Olein
Dietary Supplement: Red Palm Olein
Primary Outcome(s)
Changes in plasma Interleukin-6 status [Time Frame: 3 years]
Secondary Outcome(s)
Secondary ID(s)
PD164/12
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history